hydrazine has been researched along with Diathesis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Majewska, R; Tomiyama, Y; Wong, TF | 1 |
Álvarez-Roman, MT; Butta, N; Coma, M; González-Porras, JR; Gutiérrez, L; Lozano, ML; Segú-Vergés, C; Valcárcel, D | 1 |
Bussel, JB; Cooper, N; Ghanima, W; Godeau, B; Rodeghiero, F | 1 |
1 review(s) available for hydrazine and Diathesis
Article | Year |
---|---|
Thrombopoietin receptor agonists: ten years later.
Topics: Animals; Benzoates; Biomarkers; Blood Coagulation; Clinical Trials as Topic; Disease Susceptibility; Humans; Hydrazines; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Signal Transduction; Thrombopoietin; Treatment Outcome | 2019 |
2 other study(ies) available for hydrazine and Diathesis
Article | Year |
---|---|
Management of primary immune thrombocytopenia in a real-world setting in Japan: eltrombopag versus corticosteroids.
Topics: Adrenal Cortex Hormones; Benzoates; Disease Management; Disease Susceptibility; Drug Therapy, Combination; Hemorrhage; Humans; Hydrazines; Japan; Kaplan-Meier Estimate; Patient Acceptance of Health Care; Platelet Count; Practice Patterns, Physicians'; Prevalence; Prognosis; Proportional Hazards Models; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Retrospective Studies; Treatment Outcome | 2021 |
Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach.
Topics: Benzoates; Biomarkers; Disease Management; Disease Susceptibility; Humans; Hydrazines; Immunomodulation; Models, Biological; Models, Molecular; Molecular Targeted Therapy; Protein Interaction Mapping; Protein Interaction Maps; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin; Signal Transduction; Structure-Activity Relationship; T-Lymphocytes; Treatment Outcome | 2021 |